![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2016
Darsow, U.; Sbornik, M.; Rombold, S.; Katzer, K.; Sonnenburg, F. von; Behrendt, H. und Ring, J.
(2016):
Phase I study on replication-defective smallpox vaccine (MVA-BN) in atopic patients.
In: Journal of investigative Dermatology, Bd. 136, Nr. 9:
S164-S164
Darsow, U.; Sbornik, M.; Rombold, S.; Katzer, K.; Sonnenburg, F. von; Behrendt, H. und Ring, J.
(2016):
Long-term safety of replication-defective smallpox vaccine (MVA-BN) in atopic eczema and allergic rhinitis.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 30, Nr. 11: S. 1971-1977
2005
Weidinger, S.; Mayerhofer, Artur; Kunz, Lars 
ORCID: https://orcid.org/0000-0003-3141-0005; Albrecht, M.; Sbornik, M.; Wunn, E.; Hollweck, R.; Ring, J. und Kohn, F. M.
(2005):
Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway.
In: Human Reproduction, Bd. 20, Nr. 2: S. 456-461
ORCID: https://orcid.org/0000-0003-3141-0005; Albrecht, M.; Sbornik, M.; Wunn, E.; Hollweck, R.; Ring, J. und Kohn, F. M.
(2005):
Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway.
In: Human Reproduction, Bd. 20, Nr. 2: S. 456-461